These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 11977998)

  • 1. The 5A6A polymorphism in the promoter of the stromelysin-1 (MMP3) gene as a risk factor for restenosis.
    Humphries S; Bauters C; Meirhaeghe A; Luong L; Bertrand M; Amouyel P
    Eur Heart J; 2002 May; 23(9):721-5. PubMed ID: 11977998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The 5A/6A polymorphism of the stromelysin-1 gene and restenosis after percutaneous coronary interventions.
    Hoppmann P; Koch W; Schömig A; Kastrati A
    Eur Heart J; 2004 Feb; 25(4):335-41. PubMed ID: 14984923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of genetic polymorphism in matrix metalloproteinase-3 on extent of coronary atherosclerosis and risk of coronary artery stenosis.
    Seifi M; Fallah S; Firoozrai M
    Arch Med Res; 2009 Oct; 40(7):600-4. PubMed ID: 20082876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 5A/6A polymorphism of the stromelysin-1 gene and angiographic restenosis after coronary artery stenting.
    Chiou KR; Chung SL; Charng MJ
    J Chin Med Assoc; 2005 Nov; 68(11):506-12. PubMed ID: 16323393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequency and time course of reocclusion and restenosis in coronary artery occlusions after balloon angioplasty versus Wiktor stent implantation: results from the Mayo-Japan Investigation for Chronic Total Occlusion (MAJIC) trial.
    Tamai H; Berger PB; Tsuchikane E; Suzuki T; Nishikawa H; Aizawa T; Fujii K; Nozaki Y; Kyo E; Kobayashi T; Reiber J; Van Weert AW;
    Am Heart J; 2004 Mar; 147(3):E9. PubMed ID: 14999211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The 5A/6A polymorphism of the matrix metalloproteinase 3 gene promoter and breast cancer.
    Krippl P; Langsenlehner U; Renner W; Yazdani-Biuki B; Köppel H; Leithner A; Wascher TC; Paulweber B; Samonigg H
    Clin Cancer Res; 2004 May; 10(10):3518-20. PubMed ID: 15161710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A single center investigation of bare-metal or drug-eluting stent restenosis from 1633 consecutive Chinese Han ethnic patients.
    Xu B; Li JJ; Yang YJ; Ma WH; Chen JL; Qiao SB; Qin XW; Yao M; Liu HB; Wu YJ; Yuan JQ; Chen J; You SJ; Dai J; Xia R; Gao RL
    Chin Med J (Engl); 2006 Apr; 119(7):533-8. PubMed ID: 16620692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiographic and three-dimensional intravascular ultrasound analysis of combined intracoronary beta radiation and self-expanding stent implantation in human coronary arteries.
    Ferrero V; Ribichini F; Heyndrickx GR; De Bruyne B; Piessens M; Carlier S; Büchi M; Matullo G; Vassanelli C; Wijns W
    Am J Cardiol; 2004 Nov; 94(10):1237-42. PubMed ID: 15541237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Percutaneous transluminal coronary angioplasty for restenosis following Palmaz-Schatz stenting: larger size balloons are more effective?].
    Kishi K; Hiasa Y; Suzuki N; Miyamoto H; Takahashi T; Hosokawa S; Tanimoto M; Otani R
    J Cardiol; 1999 Aug; 34(2):55-60. PubMed ID: 10466086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic markers of restenosis after coronary angioplasty and after stent implantation.
    Petrovic D; Peterlin B
    Med Sci Monit; 2005 Apr; 11(4):RA127-35. PubMed ID: 15795709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The functional (-1171 5A-->6A) polymorphisms of matrix metalloproteinase 3 gene as a risk factor for oral submucous fibrosis among male areca users.
    Tu HF; Liu CJ; Chang CS; Lui MT; Kao SY; Chang CP; Liu TY
    J Oral Pathol Med; 2006 Feb; 35(2):99-103. PubMed ID: 16430740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recurrent in-stent restenosis is not associated with the angiotensin-converting enzyme D/I, angiotensinogen Thr174Met and Met235Thr, and the angiotensin-II receptor 1 A1166C polymorphism.
    Gross CM; Perrot A; Geier C; Posch MG; Hassfeld S; Kramer J; Schmidt S; Derer W; Dietz R; Ozcelik C
    J Invasive Cardiol; 2007 Jun; 19(6):261-4. PubMed ID: 17541127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p27kip1-838C>A single nucleotide polymorphism is associated with restenosis risk after coronary stenting and modulates p27kip1 promoter activity.
    van Tiel CM; Bonta PI; Rittersma SZ; Beijk MA; Bradley EJ; Klous AM; Koch KT; Baas F; Jukema JW; Pons D; Sampietro ML; Pannekoek H; de Winter RJ; de Vries CJ
    Circulation; 2009 Aug; 120(8):669-76. PubMed ID: 19667240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intracoronary beta-radiation for the treatment of patients at very high risk for recurrence of in-stent restenosis: a single center experience.
    Parenti DZ; Marsico F; Tosi G; Catalano G; Maiello L; Milone F; Carcagnì A; Pron PG; Orecchia R; Presbitero P
    Ital Heart J; 2003 Mar; 4(3):199-204. PubMed ID: 12784747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug-eluting stents in bifurcation lesions: to stent one branch or both?
    Assali AR; Assa HV; Ben-Dor I; Teplitsky I; Solodky A; Brosh D; Fuchs S; Kornowski R
    Catheter Cardiovasc Interv; 2006 Dec; 68(6):891-6. PubMed ID: 17086532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated whole-blood tissue factor procoagulant activity as a marker of restenosis after percutaneous transluminal coronary angioplasty and stent implantation.
    Tutar E; Ozcan M; Kilickap M; Gülec S; Aras O; Pamir G; Oral D; Dandelet L; Key NS
    Circulation; 2003 Sep; 108(13):1581-4. PubMed ID: 12975255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The interleukin 1B-511 polymorphism is associated with the risk of developing restenosis after coronary stenting in Mexican patients.
    Miranda-Malpica E; Martínez-Rios MA; Fragoso JM; Delgadillo-Rodríguez H; Rodríguez-Pérez JM; González-Quesada C; Martínez-Rodríguez N; Saldaña-Mendoza A; Peña-Duque MA; Vargas-Alarcón G
    Hum Immunol; 2008 Feb; 69(2):116-21. PubMed ID: 18361937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors predictive of cardiac events and restenosis after sirolimus-eluting stent implantation in small coronary arteries.
    Lee CW; Suh J; Lee SW; Park DW; Lee SH; Kim YH; Hong MK; Kim JJ; Park SW; Park SJ
    Catheter Cardiovasc Interv; 2007 May; 69(6):821-5. PubMed ID: 17191211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stenting alone versus debulking and debulking plus stent in branch ostial lesions of native coronary arteries.
    Chung CM; Nakamura S; Tanaka K; Tanigawa J; Kitano K; Akiyama T; Matoba Y; Katoh O
    Heart Vessels; 2004 Sep; 19(5):213-20. PubMed ID: 15372295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Latin American randomized trial of balloon angioplasty versus coronary stenting in diabetic patients with small vessel reference size (Latin American Small Vessel [LASMAL II] Trial): immediate and long-term results.
    Rodriguez AE; Rodriguez Alemparte M; Fernandez Pereira C; Vigo CF; Sampaolesi A; Bernardi V; Marchand E; Tronge J; Palacios IF;
    Am Heart J; 2005 Jul; 150(1):188. PubMed ID: 16086559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.